CDC Extends Order Suspending Entry of Travelers from Ebola-Affected Countries

The Centers for Disease Control and Prevention, operating under the Department of Health and Human Services, announced an extension of its ongoing travel restrictions for individuals arriving from regions experiencing outbreaks of quarantinable communicable diseases. The latest directive, issued on November 10, 2026, maintains the suspension of entry for covered persons who departed from or were present within the Democratic Republic of the Congo, Uganda, or South Sudan during the preceding 21 days. This measure is authorized under Sections 362 and 365 of the Public Health Service Act and will remain in force until 4:59 p.m. Eastern Standard Time on December 10, 2026.

Background and Regulatory Framework

The federal government first initiated restrictions on May 18, 2026, when the acting director of the Centers for Disease Control and Prevention signed an initial order barring entry to individuals present in specified nations within a 21-day window. Subsequent amendments and consecutive thirty-day extensions followed in June, July, August, September, and October. A significant regulatory update occurred on May 22, when the assistant secretary for health signed an amended order reflecting updates to federal regulations at title 42 of the Code of Federal Regulations, which removed exemptions for lawful permanent residents from such public health orders. Agency officials note that the current restrictions apply broadly to all non-citizens and non-nationals regardless of origin, aiming to limit overall traveler volume and protect the domestic population from the Bundibugyo virus strain identified in Central Africa.

Public Comments and Agency Responses

During the public comment period associated with the October order, the Centers for Disease Control and Prevention received eight submissions from various stakeholders. Several commenters advocated for evidence-based risk assessments, transparent data publication, and targeted screening protocols as alternatives to sweeping entry bans. Other respondents questioned the inclusion of lawful permanent residents and asked for clear, measurable criteria for adding or removing specific countries from the restricted list. In its published response, the agency defended its reliance on broad geographic thresholds rather than individualized exposure assessments. Agency officials stated that logistical constraints, the high volume of international air traffic, and the complex nature of potential exposures make individualized screening operationally impractical. Furthermore, the agency noted that requests to alter the treatment of lawful permanent residents fall outside the scope of the immediate notice because those rules are governed by broader administrative rulemaking procedures.

Future Trajectories and Ongoing Oversight

The temporary nature of the November order is designed to facilitate continuous assessment of the epidemiological situation and risk profile surrounding the outbreak. The agency stated that it will continue monitoring public health data, international mitigation measures, and infection rates to determine whether the statutory criteria for the order remain satisfied. Should conditions change materially, federal health authorities retain the discretion to modify, narrow, or rescind the restrictions prior to the expiration date. Public comments on the current order are open through November 30, 2026, providing an ongoing mechanism for stakeholder engagement.